
### [NCIT:C2915](http://purl.obolibrary.org/obo/NCIT_C2915)
**Label:** Carcinoid Tumor

**Subclasses:** [NCIT:C5547](http://purl.obolibrary.org/obo/NCIT_C5547) (Rectal Neuroendocrine Tumor G1), [NCIT:C5229](http://purl.obolibrary.org/obo/NCIT_C5229) (Ovarian Carcinoid Tumor), [NCIT:C4637](http://purl.obolibrary.org/obo/NCIT_C4637) (Intestinal Neuroendocrine Tumor G1), [NCIT:C7864](http://purl.obolibrary.org/obo/NCIT_C7864) (Recurrent Digestive System Neuroendocrine Tumor G1), [NCIT:C4038](http://purl.obolibrary.org/obo/NCIT_C4038) (Lung Carcinoid Tumor), [NCIT:C5501](http://purl.obolibrary.org/obo/NCIT_C5501) (Cecum Neuroendocrine Tumor G1), [NCIT:C5820](http://purl.obolibrary.org/obo/NCIT_C5820) (Esophageal Neuroendocrine Tumor G1), [NCIT:C6431](http://purl.obolibrary.org/obo/NCIT_C6431) (Metastatic Carcinoid Tumor), [NCIT:C7861](http://purl.obolibrary.org/obo/NCIT_C7861) (Localized Digestive System Neuroendocrine Tumor G1), [NCIT:C6430](http://purl.obolibrary.org/obo/NCIT_C6430) (Thymic Carcinoid Tumor), [NCIT:C95982](http://purl.obolibrary.org/obo/NCIT_C95982) (Ampulla of Vater Neuroendocrine Tumor G1), [NCIT:C5024](http://purl.obolibrary.org/obo/NCIT_C5024) (Prostate Carcinoid Tumor), [NCIT:C5861](http://purl.obolibrary.org/obo/NCIT_C5861) (Extrahepatic Bile Duct Neuroendocrine Tumor G1), [NCIT:C7862](http://purl.obolibrary.org/obo/NCIT_C7862) (Regional Digestive System Neuroendocrine Tumor G1), [NCIT:C5170](http://purl.obolibrary.org/obo/NCIT_C5170) (Breast Carcinoid Tumor), [NCIT:C5171](http://purl.obolibrary.org/obo/NCIT_C5171) (Metastatic Breast Carcinoid Tumor), [NCIT:C128044](http://purl.obolibrary.org/obo/NCIT_C128044) (Cervical Low Grade Neuroendocrine Tumor, Grade 2), [NCIT:C4638](http://purl.obolibrary.org/obo/NCIT_C4638) (Small Intestinal Neuroendocrine Tumor G1), [NCIT:C7709](http://purl.obolibrary.org/obo/NCIT_C7709) (Digestive System Neuroendocrine Tumor G1), [NCIT:C128043](http://purl.obolibrary.org/obo/NCIT_C128043) (Cervical Low Grade Neuroendocrine Tumor, Grade 1), [NCIT:C6428](http://purl.obolibrary.org/obo/NCIT_C6428) (Descending Colon Neuroendocrine Tumor G1), [NCIT:C6427](http://purl.obolibrary.org/obo/NCIT_C6427) (Ascending Colon Neuroendocrine Tumor G1), [NCIT:C72074](http://purl.obolibrary.org/obo/NCIT_C72074) (Atypical Carcinoid Tumor), [NCIT:C6424](http://purl.obolibrary.org/obo/NCIT_C6424) (Meckel Diverticulum Neuroendocrine Tumor G1), [NCIT:C6423](http://purl.obolibrary.org/obo/NCIT_C6423) (Hindgut Carcinoid Tumor), [NCIT:C6426](http://purl.obolibrary.org/obo/NCIT_C6426) (Transverse Colon Neuroendocrine Tumor G1), [NCIT:C45551](http://purl.obolibrary.org/obo/NCIT_C45551) (Lung Atypical Carcinoid Tumor), [NCIT:C96543](http://purl.obolibrary.org/obo/NCIT_C96543) (Anal Canal Neuroendocrine Tumor G1), [NCIT:C6425](http://purl.obolibrary.org/obo/NCIT_C6425) (Duodenal Neuroendocrine Tumor G1), [NCIT:C115245](http://purl.obolibrary.org/obo/NCIT_C115245) (Metastatic Digestive System Neuroendocrine Tumor G1), [NCIT:C6024](http://purl.obolibrary.org/obo/NCIT_C6024) (Laryngeal Carcinoid Tumor), [NCIT:C5497](http://purl.obolibrary.org/obo/NCIT_C5497) (Colon Neuroendocrine Tumor G1), [NCIT:C6422](http://purl.obolibrary.org/obo/NCIT_C6422) (Midgut Carcinoid Tumor), [NCIT:C6421](http://purl.obolibrary.org/obo/NCIT_C6421) (Foregut Carcinoid Tumor), [NCIT:C96160](http://purl.obolibrary.org/obo/NCIT_C96160) (Colorectal Neuroendocrine Tumor G1), [NCIT:C6360](http://purl.obolibrary.org/obo/NCIT_C6360) (Testicular Carcinoid Tumor), [NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor), [NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor), [NCIT:C45719](http://purl.obolibrary.org/obo/NCIT_C45719) (Thymic Atypical Carcinoid Tumor), [NCIT:C118810](http://purl.obolibrary.org/obo/NCIT_C118810) (Childhood Carcinoid Tumor), [NCIT:C126773](http://purl.obolibrary.org/obo/NCIT_C126773) (Uterine Corpus Carcinoid Tumor), [NCIT:C96924](http://purl.obolibrary.org/obo/NCIT_C96924) (Gallbladder Neuroendocrine Tumor G1), 

**Class expressions from DL-Learner:**

- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C36855](http://purl.obolibrary.org/obo/NCIT_C36855) (Malignant Neuroendocrine Polygonal Cell))) 54.55%
- Thing 52.66%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 39.90%
- [NCIT:C36933](http://purl.obolibrary.org/obo/NCIT_C36933) (Neoplastic Neuroendocrine Polygonal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 39.90%


